Performance-Based Quality Specifications: The Relationship Between Process Critical Control Parameters, Critical Quality Attributes, and Clinical Performance
- 1 April 2011
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 100 (4) , 1566-1575
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- A New Definition of Pharmaceutical Quality: Assembly of a Risk Simulation Platform to Investigate the Impact of Manufacturing/ Product Variabcpility on Clinical PerformanceJournal of Pharmaceutical Sciences, 2010
- Investigation of the Statistical Power of the Content Uniformity Tests Using Simulation StudiesJournal of Pharmaceutical Innovation, 2009
- A Framework for the Development of Design and Control SpacesJournal of Pharmaceutical Innovation, 2008
- Risk-based Quality by Design (QbD): A Taguchi Perspective on the Assessment of Product Quality, and the Quantitative Linkage of Drug Product Parameters and Clinical PerformanceJournal of Pharmaceutical Innovation, 2008
- Three-Stage Sequential Statistical Dissolution Testing RulesJournal of Biopharmaceutical Statistics, 2004
- Theophylline in AsthmaNew England Journal of Medicine, 1996
- SIMPLS: An alternative approach to partial least squares regressionChemometrics and Intelligent Laboratory Systems, 1993
- Partial least-squares regression: a tutorialAnalytica Chimica Acta, 1986
- Avoidance of Adverse Effects during Chronic Therapy with TheophyllineDrug Intelligence & Clinical Pharmacy, 1980
- Theophylline-Induced Seizures in AdultsAnnals of Internal Medicine, 1975